BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
XETRA:BNN
Price:
3.29 EUR
9.67%
Updated:
Apr 18, 2024
ROCE
Return on Capital Employed
Return on Capital Employed
-10.5%
Current
-14%
Average
5.8%
Industry
Negative for the last year
-10.5%
Negative average
-14%
Better
than average
Worse
than industry value
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE
=-10.5%
EBIT
/
-5.7m
Capital Employed
53.6m
ROCE Across Competitors
ROCE Comparison
BRAIN Biotech AG Competitors
BRAIN Biotech AG Competitors
| Country | DE |
| Market Cap | 71.9m EUR |
| ROCE |
-11%
|
| Country | JP |
| Market Cap | 12.7T JPY |
| ROCE |
17%
|
| Country | US |
| Market Cap | 78.9B USD |
| ROCE |
22%
|
| Country | US |
| Market Cap | 62.6B USD |
| ROCE |
12%
|
| Country | CH |
| Market Cap | 41.6B CHF |
| ROCE |
16%
|
| Country | CH |
| Market Cap | 35.9B CHF |
| ROCE |
12%
|
| Country | CN |
| Market Cap | 273.4B CNY |
| ROCE |
17%
|
| Country | IN |
| Market Cap | 2.7T INR |
| ROCE |
40%
|
| Country | US |
| Market Cap | 31.7B USD |
| ROCE |
14%
|
| Country | US |
| Market Cap | 31.4B USD |
| ROCE |
5%
|
| Country | CH |
| Market Cap | 27B EUR |
| ROCE |
-2%
|
Profitability Report
View the profitability report to see the full profitability analysis for BRAIN Biotech AG.
See Also
Discover More
What is Return on Capital Employed?
ROCE, or Return on Capital Employed, is a financial ratio that measures a company’s profitability in relation to the capital it employs.
ROCE
=-10.5%
EBIT
/
-5.7m
Capital Employed
53.6m
What is the ROCE of BRAIN Biotech AG?
Based on BRAIN Biotech AG's most recent financial statements, the company has ROCE of -10.5%.
You don't have any saved screeners yet
